COVID-19 mRNA vaccine (Genexine/Phi Biomed/POSTECH)

N/A

Report date: 2025/12/18 17:46:37

Base Information

Drug NameCOVID-19 mRNA vaccine (Genexine/Phi Biomed/POSTECH)
Drug Alias NameSARS-CoV-2 mRNA vaccine + GX-17 (Genexine/Phi Biomed/POSTECH)
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Nucleic acid vaccine > RNA vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesGannex Pharma Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesPHI Biomed Co LtdGannex Pharma Co LtdPohang University Of Science And Technology
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A